Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,694
datasets available to search
ShareScore release 0.9.0
Dataset results
10,694 results for “carcinoma,”
Transcriptome sequencing of laryngeal squamous cell carcinoma and paired adjacent normal mucosa tissues
GEO Series GSE142083. Homo sapiens. 106 samples. Type: Expression profiling by high throughput sequencing.
Genomic profiles of oxidative stress-induced rat renal cell carcinomas
GEO Series GSE36101. Rattus norvegicus. 16 samples. Type: Expression profiling by array.
Overexpression of microRNA-375 in medullary thyroid carcinoma cells hinders cell proliferation and improves the vandetanib efficacy effect in vitro
GEO Series GSE67742. Homo sapiens. 8 samples. Type: Expression profiling by array.
Identifying novel drivers of human hepatocellular carcinoma and revealing clinical relevance as early diagnostic and prognostic biomarker
GEO Series GSE89377. Homo sapiens. 107 samples. Type: Expression profiling by array.
Naturally-occurring canine invasive urothelial carcinoma harbors luminal and basal transcriptional subtypes found in human muscle invasive bladder cancer
GEO Series GSE110661. Canis lupus familiaris. 33 samples. Type: Expression profiling by high throughput sequencing.
Gene Expression Profiling of Oral Squamous Cell Carcinoma
GEO Series GSE23558. Homo sapiens. 32 samples. Type: Expression profiling by array.
Genome-wide chromatin accessibility and gene expression profiling of renal cell carcinoma and matched normal kidney tubules [RNA-Seq]
GEO Series GSE117313. Homo sapiens. 10 samples. Type: Expression profiling by high throughput sequencing.
Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma
GEO Series GSE71963. Homo sapiens. 48 samples. Type: Expression profiling by array.
CNA analysis of ionizing radiation related basal cell carcinoma
GEO Series GSE97334. Homo sapiens. 6 samples. Type: Genome variation profiling by genome tiling array.
Spatial transcriptomics for high-grade serous ovarian carcinoma who were treated with Olaparib maintenance therapy
GEO Series GSE288483. Homo sapiens. 8 samples. Type: Other.
Focal gains of VEGFA and molecular classification of hepatocellular carcinoma
GEO Series GSE9829. Homo sapiens. 288 samples. Type: Expression profiling by array; Genome variation profiling by SNP array; SNP genotyping by SNP array.
Dual edged mechanisms of a tomatine in hepatocellular carcinoma by suppression of Wnt/b Catenin signaling versus RelB driven resistance in tumor therapy
GEO Series GSE308098. Homo sapiens. 16 samples. Type: Expression profiling by high throughput sequencing.
Squamous cell carcinoma of the lung: gene expression and network analysis during carcinogenesis (additional data)
<p>Additional files regarding the results of the research.</p>
Data from: Clonal relatedness between lobular carcinoma in situ and synchronous malignant lesions
INTRODUCTION: Lobular carcinoma in situ (LCIS) has been accepted as a marker of risk for the development of invasive breast cancer, yet modern models of breast carcinogenesis include LCIS as a precursor of low-grade carcinomas. We provide evidence favoring a clonal origin for LCIS and synchronous estrogen receptor-positive malignant lesions of the ductal and lobular phenotype. METHODS: Patients with prior LCIS undergoing mastectomy were identified preoperatively from 2003-2008. Specimens were widely sampled, and frozen blocks were screened for LCIS and co-existing malignant lesions, and subject to microdissection. Samples from 65 patients were hybridized to the Affymetrix SNP 6.0 array platform. Cases with both an LCIS sample and an associated ductal carcinoma in situ (DCIS) or invasive tumor sample were evaluated for patterns of somatic copy number changes to assess evidence of clonal relatedness. RESULTS: LCIS was identified in 44 of the cases, and among these, a DCIS and/or invasive lesion was also identified in 21 cases. A total of 17 tumor pairs had adequate DNA/array data for analysis, including 9 pairs of LCIS/invasive lobular cancer (ILC), 4 pairs of LCIS/DCIS, and 4 LCIS/invasive ductal cancer (IDC). Overall, 7 pairs (41%) were judged to be clonally related; in 5 (29%), evidence suggested clonality but was equivocal, and 5 (29%) were considered independent. Clonal pairs were observed with all matched lesion types and low and high histological grades. We also show anecdotal evidence of clonality between a patient-matched triplet of LCIS, DCIS, and IDC. CONCLUSIONS: Our results support the role of LCIS as a precursor in the development of both high- and low-grade ductal and lobular cancers.
Dataset related to the paper "Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy"
<p>Dataset related to the paper "Prognostic role of systemic inflammation indexes in metastatic urothelial carcinoma treated with immunotherapy"</p>
Figure 9 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 9 Viability percent for free GEF, GEF-loaded NPs, ZSM-5 NPs, and media (DMSO).
Figure 3 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 3 FTIR data of (A)GFT, (B) ZSM-5 loaded nanoparticles and (C) ZSM-5 NP.
Figure 6 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 6 Particle size distribution of the prepared ZSM-5-GFT nanoparticles.
Figure 1 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 1 Ring structures and main channel dimensions in ZSM-5 (Alnaama, 2015).
Figure 5 from: Al-Sahlawi F, Al-Ani I, El-Tanani M, Farooq HA (2024) Preparation and evaluation of biological activity of ZSM-5 nanoparticles loaded with gefitinib for the treatment of non-small cell lung carcinoma. Pharmacia 71: 1-12. https://doi.org/10.3897/pharmacia.71.e112449
Figure 5 SEM photo of the prepared ZSM-5 nanoparticles
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.